The authors' fine-needle aspiration (FNA) clinic opened in 2010, allowing cytopathologists to increase their proficiency and experience in FNA performance. Here, they report their 5-year experience. METHODS: The FNA clinic log book and the institution's database were retrospectively reviewed to record patients' demographics, the number of 
INTRODUCTION
Tumor sampling with the use of a small-gauge needle was introduced in the United States by Martin and Ellis in the 1930s; however, it only gained popularity in the 1950s, after extensive use in Europe, particularly in Scandinavia.
1,2 Ultrasound (US)-guided fine-needle aspiration (USG-FNA) offers many advantages: it is safe, minimally invasive, causes minimal discomfort for the patient, allows sampling from multiple sites in the same sitting, and produces a preoperative diagnosis with rapid, high diagnostic accuracy. In addition, it is economic, involving minimal equipment, and can be performed in an office setting while increasing the contact and direct communication with patients. Triage for ancillary studies (bacterial cultures, immunocytochemistry, flow cytometry, cytogenetics, molecular testing) is also possible during the procedure. USG-FNA permits visualization of the needle tip in the target lesion and US monitoring during the procedure to protect the patient's airway and major vessels and to facilitate an accurate biopsy of small, nonpalpable lesions. 3 US guidance is superior to palpation for obtaining adequate material for an accurate cytologic evaluation 4 ; however, USG-FNA requires practice and skills, and the diagnostic accuracy depends on the experience of the aspirator. 4, 5 It involves cost and maintenance of the US machine, obtaining competency, and constantly practicing. 6 Over time, it has been demonstrated that USG-FNA is a reliable tool for providing diagnosis. Although USGFNAs were initially performed by radiologists, surgeons, and endocrinologists, eventually, it was cytopathologists who proved to own the tools necessary to successfully perform USG-FNAs, 3, 6 providing highly accurate diagnoses with optimal turnaround time and a minimal number of passes because of the ability to perform rapid on-site evaluation (ROSE). The final report integrates radiologic, clinical, and pathologic findings in a timely fashion.
In the current study, we report the experience of operating an FNA clinic in an outpatient setting related to a large tertiary care center. Our FNA clinic, which opened in 2010, allowed cytopathologists to increase their proficiency and experience in USG-FNA performance. Overcoming challenges to build a successful operating clinic was not easy. Hurdles to a pathologist-operated FNA clinic included pathologists' comfort level with direct patient interaction and procedure performance, the cost of initial equipment investment, physical facility, regulatory requirements, and procedure manual set-up as well as referring clinicians' skepticism about the ability of pathologists to perform USG-FNAs and the cultural changes required to divert patients from the traditional practices that performed FNAs.
Although cytopathologists are performing USGFNAs, 7 only a few publications have reported the experience, benefits, and logistics of operating an FNA clinic over time. 6, 8, 9 We describe our 5-year experience, including comparison among performers and marketing strategies. Our FNA clinic is operated by experienced cytopathologists, a cytopathology fellow, and sometimes a resident.
MATERIALS AND METHODS
The FNA clinic log book and the institution's database were retrospectively reviewed to record patient demographics, FNAs per year per cytopathologist, the number of passes, ROSE and diagnosis at the time of the FNA procedure, concordance between the interpretation at adequacy and the final diagnosis, as well as follow-up histology when available. Data from January 2011 through December 2015 were collected and analyzed. We compared the numbers and the type of cases per year and variations among cytopathologists. The clinic was opened in late 2010, and data for that year included only a few months; therefore, 2010 data were eliminated for accurate comparison among the remaining years. Initially, 3 senior cytopathologists (with >10 years of experience) operated the FNA clinic. Each had prior experience performing FNAs by palpation alone and had acquired training in USG-FNA on commercial phantoms and, subsequently, on patients. Later on, junior cytopathologists with experience performing USG-FNAs during their cytopathology fellowships were included in the operation. Attending professional conferences, such as the American Society for Cytopathology and College of American Pathologists annual meetings, allowed for interaction with cytopathologists who had experience in USG-FNAs, sharing of best practices at round tables and training sessions for USG-FNA performance techniques.
Interaction with other cytopathologists, endocrinologists, and radiologists performing USG-FNAs, in conjunction with the goals of balancing image quality, ease of use, size of facility, and cost, lead us to purchase a portable GE Healthcare LOGIQ e system with a docking cart and a 12L probe (GE Healthcare, Little Chalfont, UK). The probe has a 10-MHz top-end frequency, providing excellent visualization of the needle in the lesion. Initial setup included training from the company representatives about the features, settings, depth of coverage, brightness, contrast, image freezing, printing, and storage. A foot pedal allows independent control by a single individual.
During each procedure, we record the dimensions and Doppler vascularity for individual nodules, using a video loop and pictures to document the needle in the lesion. The images and video clips are stored on both the internal memory of the US machine and on a removable memory stick, from which they are periodically transferred to our internal drive, accessible to performing cytopathologists. Sterile gel, disposable probe covers, and an ethyl chloride "cold" spray to anesthetize the area are used. A 10-mL syringe with a 27-gauge to 22-gauge needle and sometimes an FNA syringe holder device (10 mL; Belpro Medical Inc, Anjou, QC, Canada) are used for aspiration, Original Article depending on the operator's preference. The patient's comfort and subsequent cooperation are vital for a successful USG-FNA. Routine use of a skin refrigerant as cutaneous anesthetic reduces the discomfort associated with the needle puncture as well as the number of needle passes. Stressrelief balls are handed to our patients during the FNA process; these distract their attention from the procedure itself while decreasing their anxiety. In addition, background music can be set up for patient relaxation.
ROSE is performed on Diff-Quik2stained slides, and compatible smears are fixed in 70% alcohol for subsequent Papanicolaou staining. The needle is rinsed in 10% buffered formalin for cell block or CytoLyt for ThinPrep preparation, depending on the material submitted.
If a lymphoproliferative disorder is suspected at the ROSE, then additional FNA passes are collected in RPMI solution to perform flow cytometry. A sterile container is used to collect material if an infection is suspected and bacterial cultures are necessary. For thyroid nodules with anticipated or previously requested molecular testing, the FNA sample is placed in the Veracyte collection tube (Veracyte, South San Francisco, Calif) and saved to perform Afirma Gene Expression Classifier analysis if necessary (Veracyte).
Patients' FNA experience is monitored by providing them evaluation surveys after the procedure. The surveys are scanned and stored for future reference. If any issues are reported, then the survey is reviewed by the medical director for discussion with staff and corrective action. The survey results are reported in monthly quality meetings.
Periodic practice on both commercially available (thyroid, breast) and "home-made" phantoms is used for competency and education. "Home-made" phantoms include chicken or turkey thighs stuffed with different "lesions": cherry tomatoes can mimic hypoechoic solid lesions, liver represents isoechoic solid lesions, whereas stuffed olives imitate mixed solid and cystic lesions (Fig.  1) . Although the "home-made" phantoms are not anatomically perfect and die rather quickly, they have a double advantage: practicing ultrasound to identify solid, cystic, isoechoic, or hypoechoic lesions, as well as obtaining an adequate material, without creating needle tracks in the tissue. They also provide a real-time experience with the possibility of lesion aspiration, as opposed to the commercially available phantoms-which, although anatomically "perfect," with ideal cystic and solid lesions-only allow visualization and practicing the USG-FNA approach; actual aspiration is not possible, and they develop needle tracks with time, impeding a good visualization of the lesions in the subsequent practicing sessions (Fig. 1) . "Home-made" phantoms allow not only identification of the targets but also allow aspiration, lesional material smearing, and staining (Fig. 2) . Inflated balloons filled with colored water can easily simulate cystic lesions; they deflate upon aspiration, and the fluid is observed in the syringe.
Acquiring patients was achieved through personal physician communication and marketing strategies. Talking points on the benefits of cytopathologist-performed FNA, such as immediate assessment, fast turnaround time and scheduling availability, were discussed at interdisciplinary conferences and with marketing staff. Flyers with frequently asked questions regarding the FNA procedures and cytopathologists' experience were created and circulated to primary care practices. 
RESULTS
In total, 474 USG-FNAs were identified within a 5-year time frame (Table 1) , most commonly of thyroid nodules (Fig. 3) , for which USG-FNA is regarded as state of the art. 8 The distribution of thyroid cases on final diagnosis, using Bethesda System for Thyroid Cytopathology categories, is illustrated in Table 2 . The number of USG-FNAs varied from year to year, although the number of referring physicians was almost constant. Cytopathologists on staff varied slightly in number, with 4 cytopathologists on service initially and, eventually, 5 cytopathologists.
There was no diagnostic discrepancy between the onsite and final diagnosis for 2 years (2012 and 2014); overall, the rate of diagnostic discrepancy decreased over time from 4.4% to 2.8% and to 2.4%, respectively (2 of 45 cases in 2011, 3 of 104 cases in 2013, and 3 of 124 cases in 2015, respectively, with a maximum of 3 cases per year) ( Table 1 ). The diagnostic discrepancies between the ROSE diagnosis and the final diagnosis can mainly be attributed to only having access to Diff-Quik-stained slides at the time of the procedure or because of additional results, such as flow cytometry, at the time of the final case sign-out (Table 3) .
Our nondiagnostic rate decreased from 13% in 2011 to 3.2 % in 2015. Cytopathologists' performance was assessed over a 3-year period ( Table 4 ). The year 2011 was excluded because the number of passes was not recorded. In 2012, there was a change in 1 of our cytopathologists on staff; because we could not follow the performance of this cytopathologist within the next 3 years, we chose not to include the data in our study.
The total number of passes was not consistently recorded until 2014, when a report template was instituted for each USG-FNA location, mainly for the thyroid, lymph nodes, and salivary glands. The number of passes for each USG-FNA decreased over time (from 3.24 in 2013 to 2.7 in 2015) ( Table 4 ). The cytology-histology concordance was 100% over time for all cytopathologists. Histologic follow-up was available in 19% of cases on average, with a lower rate in 2015 because of a shorter timeframe after the initial FNA (Table 1) .
DISCUSSION
Our nondiagnostic rate has decreased over the years since opening the FNA clinic, in part because of continuous practice with phantoms and increased experience with patients. We improved our technique over time by accumulating experience and because our cytopathologists attended the College of American Pathologists training in USG-FNA. 10 In addition, cytopathologists are eligible to participate in the Endocrine Certification in Neck Ultrasound Program offered by the American Association of Clinical Endocrinologists. 11 None of our cytopathologists, however, chose this path. Our data support acceptable diagnostic rates in cytopathologist-performed USG-FNAs, but additional comparisons with other subspecialties, such as endocrinology and radiology, are still needed. DiMaggio et al reported comparable results from cytopathologists and interventional radiologists, concluding that cytopathologists offer a rapid interpretation and reliable FNA service, which are appreciated by clinicians. 6 Lieu demonstrated that USG-FNA results are optimal when the cytopathologist is both performer and interpreter, 12 whereas Singh et al observed that FNAs performed by cytopathologists had lower inadequacy rates compared with those performed by noncytopathologists. 13 Similar results were reported by Kaur and Sivakumar. 14 Wu et al demonstrated increased accuracy in diagnostic of the FNAs performed by cytopathologists versus clinicians (96% vs 67%). 15 Moreover, when cytopathologists are assisting other clinicians to only perform ROSE but not the USG-FNAs by themselves, the process not only takes a greater amount of time but also might not produce the best results 4 and may not be cost effective. The number of USG-FNA passes can vary with the need for ancillary studies, such as flow cytometry for a suspected lymphoproliferative disorder. Additional passes may be required for a good cell block when suspecting malignancy, with a subsequent need for immunocytochemistry. Molecular studies may be necessary in case of a thyroid nodule with repeated diagnoses of atypia of undetermined significance or as requested by the clinicians if a prior atypia of undetermined significance diagnosis was rendered at a different institution.
Thyroid nodules were the most common sites sampled by USG-FNA, similar to prior reports. 1 Firsthand visualization of the US images allows cytopathologists to make an informed decision about which nodules are the most amenable to biopsy and, along with sparing patients from unnecessary passes, provides real-time evaluation of clinically suspicious lesions as well as the most accurate and rapid clinical correlation. FNAs performed by cytopathologists have a high rate of ROSE/adequacy and a low diagnostic discrepancy rate. Constant practice results in better patient care, decreasing the nondiagnostic rate, improving quality, and overall providing better patient care. 5, 6 In our institution, the turnaround time from the moment of performing the USG-FNA until sending the final report to the referring clinician is approximately 2 business days, decreasing patients' anxiety and permitting faster surgical decisions. However, when an unexpected diagnosis is suspected, a preliminary diagnosis can be given on the same day of the procedure by directly contacting the referring clinician. Similarly, if ancillary studies are performed, then the clinicians are promptly informed, which promotes good communication, assuring continuous referral. In addition to ROSE, providing patients with a preliminary diagnosis right after the procedure can decrease anxiety over a long-waited, uncertain-and possibly unfavorable-diagnosis.
USG-FNA service provided by cytopathologists is financially competitive, 6, 16 because it reduces the number of repeated biopsies and serves to triage specimens for ancillary studies. Auxiliary personnel (US technicians, nurses, etc) are not necessary. At our institution, the already hired secretarial personnel schedule the FNA procedures. The cytopathology fellow is responsible for setting up the procedure and interviewing the patient while making sure the supplies are always provided, ensuring smooth running of the FNA clinic. Our clinic is located within the pathology offices area, which saves time by allowing cytopathologists to return to their regular sign-out schedule right after the procedure. Procedures can be scheduled from Monday to Friday, offering patients the liberty of choosing the most convenient day and time for them. We chose to reserve 2 hours per patient. Occasionally, we accommodate impromptu cases if needed, at clinicians' request. Providing ease of scheduling, courteous interactions, and a comfortable environment for the patients and family are essential. Ultimately, the success of the FNA clinic is based on the patients' feedback to the referring clinicians as well as communication with family and friends.
Although data are limited, the number of the USGFNAs performed by cytopathologists is increasing. This could be because of the College of American Pathologists course provided to cytopathologists, American Society for Cytopathology USG-FNA scientific sessions, better promotion of our profession, proficiency in performing USG-FNAs, and awareness of the impact on patient care.
In the end, the most significant and rewarding aspect of an FNA clinic is the positive patient experience, with patients reassured that they were treated with respect and received optimal care. Sometimes, previous patients refer family and friends to us. Clinicians are satisfied to receive the final results in a timely fashion, which allows them to make a fast, informative clinical decision. This is the best marketing strategy for obtaining referrals and maintaining a good relationship with our clinicians. Good relationships with our interventionalists colleagues and optimal communication with clinicians can prepare the ground for opening new US-FNA clinics operated by cytopathologists to add patient-centered value. Meetings with decision-making institutional designees and interdepartmental conferences can help them better understand why cytopathologists are the best to perform FNAs and must be part of the care team.
In the current study, we shared our experience of opening an FNA clinic and brought strong arguments to the table to help the expansion of cytopathologist-operated FNA clinics in the near future. The new generation of interventional cytopathologists who are proficient in performing USG-FNAs is proving to be successful in providing superlative FNA services and an excellent patient experience.
